We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Sphere Fluidics and Heriot-Watt University Partner To Develop Next Generation Droplet Generator Instrumentation

Sphere Fluidics and Heriot-Watt University Partner To Develop Next Generation Droplet Generator Instrumentation content piece image
Credit: ronymichaud/Pixabay
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, have announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK’s innovation agency. The grant will facilitate the development of novel droplet generator instrumentation, which will be used to expand Sphere Fluidics’ portfolio of microfluidic instruments for advanced biologics discovery and therapeutic cell line development.

Awarded to promote the collaboration of knowledge, technology and skills within the UK Knowledge Base, the KTP has been granted to Sphere Fluidics, in partnership with Dr. Graeme Whyte, Associate Professor at Heriot-Watt University. The two-year project will develop next-generation intelligent instrumentation and advance research across a range of picodroplet techniques, allowing scientists to discover rare cell phenotypes and to help to solve a range of biological questions ranging from antibody discovery to antimicrobial resistance, enzyme evolution and synthetic biology. The novel platform for semi-automated picodroplet production will be employed by the Company to improve control of droplet production, using advanced imaging technology.

As part of the project, Dr. John McGrath has been appointed to Sphere Fluidics’ team as a Research Scientist in physics and engineering, to support the transfer of cutting-edge research into the Company’s portfolio of single cell analysis instruments, including for several new commercial products. Used by researchers in a number of application areas, Sphere Fluidics’ picodroplet-based technologies provide improved throughput, accuracy, and sensitivity to enable leading-edge research and accelerate biopharmaceutical discovery and development.